Management of Leptospirosis-Induced Acute Liver Failure
Treat leptospirosis-induced acute liver failure with immediate antibiotic therapy (doxycycline or ceftriaxone), aggressive supportive care following standard sepsis principles, and early consideration for liver transplantation evaluation if hepatic encephalopathy or severe coagulopathy develops.
Immediate Antibiotic Therapy
Start antibiotics immediately upon clinical suspicion—do not wait for serological confirmation. Use either:
- Doxycycline (100 mg IV/PO twice daily), or
- Ceftriaxone (1-2 g IV daily)
Recent case series demonstrate excellent outcomes when antibiotics are initiated promptly, even before diagnostic confirmation 1, 2, 3. The 2026 Australian ICU study showed 100% survival in 60 critically ill leptospirosis patients when standard sepsis management was applied early 1.
Supportive Care Framework
Apply contemporary sepsis management principles while awaiting leptospirosis confirmation:
Fluid Management
- Conservative fluid resuscitation rather than aggressive volume loading
- Avoid fluid overload, which can worsen hepatic congestion and pulmonary complications
Hemodynamic Support
- Vasopressors for shock (80% of severe cases require this) 1
- Short-course hydrocortisone only for refractory hypotension requiring vasopressor support
Renal Replacement Therapy
- Initiate hemodialysis or continuous renal replacement therapy using standard indications (severe acidosis, hyperkalemia, uremia, fluid overload)
- Approximately 20% of ICU patients with leptospirosis require renal support 1
Respiratory Support
- Lung-protective ventilation strategy if mechanical ventilation needed (tidal volume 6 mL/kg ideal body weight)
- Consider ECMO for refractory respiratory failure in select cases 1
Liver-Specific Management
Monitoring and Assessment
The general ALF guidelines 4, 5 apply, but leptospirosis has unique features:
- Marked hyperbilirubinemia (often >20 mg/dL) with disproportionately modest transaminase elevation
- Coagulopathy and thrombocytopenia are common
- Hepatic encephalopathy indicates severe disease requiring transplant evaluation
Intracranial Pressure Management
Do not use empiric ICP-lowering therapies (mannitol, hypertonic saline, hyperventilation) as these have not shown mortality benefit and carry significant risks 4. Only monitor ICP if specific clinical indication exists and intervention is planned.
Extracorporeal Liver Support
While general ALF guidelines recommend against routine use 4, there is one case report of successful MARS (Molecular Adsorbent Recirculating System) dialysis in leptospirosis-induced ALF with complete recovery 6. Consider albumin dialysis as a bridge to recovery or transplantation in severe cases with:
- Hepatic encephalopathy grade III or higher
- Extreme hyperbilirubinemia (>30 mg/dL)
- Refractory coagulopathy
However, this should be viewed as experimental and used only in centers with expertise.
Transplant Evaluation
List patients for urgent liver transplantation if they develop:
- Progressive hepatic encephalopathy (grade III-IV)
- Severe coagulopathy unresponsive to vitamin K and fresh frozen plasma
- Multi-organ failure despite maximal support
The AASLD guidelines emphasize early contact with transplant centers for any ALF patient 5. However, leptospirosis differs from other causes—most patients recover with supportive care alone if treated early 1, 3, 7.
Blood Product Management
Use restrictive transfusion strategy:
- Transfuse platelets only for active bleeding or before invasive procedures
- Fresh frozen plasma for clinically significant bleeding with coagulopathy
- Avoid prophylactic transfusions based on laboratory values alone
Critical Pitfalls to Avoid
- Delayed antibiotic initiation: Start empiric therapy based on clinical suspicion (fever, jaundice, renal dysfunction, exposure history) rather than waiting for serology
- Aggressive fluid resuscitation: This worsens outcomes; use conservative approach
- Empiric corticosteroids: Only use short-course hydrocortisone for vasopressor-dependent shock, not as primary therapy
- Premature transplant listing: Unlike other ALF causes, leptospirosis has excellent recovery potential with supportive care—transplant is rarely needed
Prognosis
With appropriate management, mortality should approach zero in well-resourced settings 1. The key is early recognition, immediate antibiotics, and meticulous supportive care. Most patients achieve complete recovery of hepatic and renal function within weeks 3, 6, 7.